881189-65-7 Usage
Uses
Used in Pharmaceutical Industry:
3-(4-chloro-3-fluorophenyl)propanoic acid is used as an anti-inflammatory agent for its ability to reduce inflammation and pain associated with various conditions.
3-(4-chloro-3-fluorophenyl)propanoic acid is used as an analgesic for its effectiveness in alleviating mild to moderate pain, making it suitable for conditions such as menstrual cramps and other forms of discomfort.
3-(4-chloro-3-fluorophenyl)propanoic acid is used as an antipyretic agent for its ability to reduce fever by lowering body temperature, providing relief in cases of elevated temperature due to illness or inflammation.
Used in Research and Development:
3-(4-chloro-3-fluorophenyl)propanoic acid serves as a valuable compound in the development of new NSAIDs and pharmaceutical formulations, contributing to the advancement of pain management and inflammation control therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 881189-65-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,1,1,8 and 9 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 881189-65:
(8*8)+(7*8)+(6*1)+(5*1)+(4*8)+(3*9)+(2*6)+(1*5)=207
207 % 10 = 7
So 881189-65-7 is a valid CAS Registry Number.
881189-65-7Relevant academic research and scientific papers
5,6,7,8-TETRAHYDRO-IMIDAZO[1,5-A]PYRAZINE COMPOUNDS
-
Page/Page column 18, (2011/05/08)
The invention relates to 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives of formula (I) wherein R1, R2, R3, and R4 are as described n the description, to salts, especially pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments; especially as orexin receptor antagonists.
5,6,7,8-TETRAHYDRO-IMIDAZO[1,5-A]PYRAZINE COMPOUNDS
-
Page/Page column 37-38, (2010/01/30)
The invention relates to 5,6,7,8-tetrahydro-imidazo[1,5- a]pyrazine derivatives of formula (I) wherein R1, R2, R3, and R4 are as described n the description, to salts, especially pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments; especially as orexin receptor antagonists.
CYCLIC AMINE DERIVATIVE OR SALT THEREOF
-
Page/Page column 22; 43, (2010/11/27)
Provided are compounds which are an NMDA antagonist having a broad safety margin and are useful as a treating agent or a preventing agent for Alzheimer's disease, cerebrovascular dementia, Parkinson's disease, ischemic apoplexy, pain, etc. Concretely prov
